• October 21, 2021

Phase 1 Clinical Trial on a ‘Novel’ Formulation of Niclosamide (DWRX2003) for COVID-19 Treatment

  • August 11, 2020

Phase 1 Clinical Trial on a ‘Novel’ Formulation of Niclosamide (DWRX2003) for COVID-19 Treatment

Mumbai, 11th August 2020. Daewoong Pharmaceutical Co., Ltd., South Korea (through its subsidiary, Daewoong Pharmaceutical India Pvt. Ltd.) and Mankind Pharma, fastest growing Indian Pharmaceutical Company, have collaborated for conducting Phase I clinical trial of a long acting intramuscular formulation of Niclosamide. The trial is designed towards addressing the need for…
Live Updates COVID-19 CASES